Pyruvate kinase activators for use in treating blood disorders

NZ802200BActive Publication Date: 2026-09-01AGIOS PHARMACEUTICALS INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: NZ802200
Authority / Receiving Office: NZ · NZ
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2018-05-18
Filing Date: 2018-08-15
Publication Date: 2026-09-01
Estimated Expiration: 2038-08-15

Application Information

Patent Timeline

18 May 2018

Priority

15 Aug 2018

Application

NZ802200

01 Sep 2026

Publication

NZ802200B

IPC: A61K31/5025; C07D513/14; A61P7/08; A61P7/06; A61P35/00; A61P3/10

Inventors: CAI, ZHENWEI; CIANCHETTA, GIOVANNI

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Smart Images

Figure 1_ABST

Patent Text Reader

Abstract

Described herein are compounds that activate pyruvate kinase, pharmaceutical compositions and methods of use thereof. These compounds are represented by Formula (I) wherein R1, R2, Ra, Rb, Rj, Rk and Q are as defined herein.

Need to check novelty before this filing date? Find Prior Art